Location History:
- Jiangsu, CN (2016)
- Taizhou, CN (2017)
- Beijing, CN (2016 - 2020)
Company Filing History:
2 out of 9 
1 out of 3 
1 out of 9 Years Active: 2016-2020
Title: Haijin Li: Innovator in Lung Cancer Diagnostics and MicroRNA Modulation
Introduction
Haijin Li is a prominent inventor based in Beijing, China, known for his significant contributions to the fields of cancer diagnostics and molecular biology. With a total of four patents to his name, he has made remarkable strides in the understanding and treatment of non-small cell lung cancer through innovative methodologies.
Latest Patents
One of Haijin Li's latest patents is titled "Serum or plasma microRNA as biomarkers for non-small cell lung cancer." This invention provides a set of non-small cell lung cancer markers that can be used for diagnosing and monitoring diseases in vitro. The markers include at least one of 26 selected detectable mature microRNAs that exist stably in human serum or plasma. The invention also includes probe combinations, a kit, and a biochip for detecting these cancer markers. The method enables extensive detection spectrum, high sensitivity, low cost, and convenient sample collection and preservation. It addresses the issues of low specificity and sensitivity found in previous single markers, significantly increasing the clinical detection rate of diseases and providing an effective means for early-stage diagnosis.
Another notable patent is "Method for modulating microRNA content in living beings and the use thereof." This invention relates to a method for modulating miRNA content in living beings, where miRNAs are delivered selectively by microparticles, microvesicles, or exosomes to the circulatory system and target cells or tissues. The invention introduces a novel combination of molecules that mediates inter-cellular communication through miRNAs secreted by cells. It also provides a method for preparing cellular microvesicles that entrap specific miRNAs, offering a new approach to modulating miRNA content across various cell types.
Career Highlights
Haijin Li has worked with notable companies in the biotechnology sector, including Micromedmark Biotech Co., Ltd. and Jiangsu Mingma Biotech Co., Ltd. His work in these organizations has contributed to advancements in biotechnological applications and cancer research.
Collaborations
Throughout his career, Haijin Li has collaborated with esteemed colleagues, including Ke Zeng and Junfeng Zhang. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Haijin Li's innovative work in the field of cancer diagnostics and microRNA modulation showcases his commitment to advancing medical science. His